Zimmer Biomet director granted phantom stock units

HIGGINS ARTHUR J reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

HIGGINS ARTHUR J reported acquisition or exercise transactions in this Form 4 filing.

ZIMMER BIOMET HOLDINGS, INC. director Arthur J. Higgins received a grant of 308.711 Phantom Stock Units on March 31, 2026 under the company’s Deferred Compensation Plan for Non-Employee Directors. Each unit is convertible on a 1-for-1 basis with common stock but is to be settled in cash.

The units are scheduled to be paid in ten annual installments, beginning within sixty days after the end of the calendar year in which Higgins’ service as a director ends. Following this award and prior accruals, including 99.385 units from dividend reinvestment on January 30, 2026, he holds 36,375.195 phantom stock units.

Insider Trade Summary

Grant/Award: 308.711 shares

Grant/Award 1 txn

Insider HIGGINS ARTHUR J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	308.711	$0.00	$0.00

Holdings After Transaction: Phantom Stock Units — 36,375.195 contracts (Direct)

Footnotes (4)

1. F1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
2. F2. The Conversion or Exercise Price of Derivative Security is 1-for-1.
3. F3. Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
4. F4. Includes 99.385 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Key Figures

Phantom units granted: 308.711 units Total phantom units after grant: 36,375.195 units Dividend reinvestment units: 99.385 units +3 more

6 metrics

Phantom units granted 308.711 units Grant on March 31, 2026 under Deferred Compensation Plan

Total phantom units after grant 36,375.195 units Holdings following the reported transaction

Dividend reinvestment units 99.385 units Accrued on January 30, 2026 via dividend reinvestment provision

Conversion ratio 1-for-1 Phantom Stock Units to Zimmer Biomet common stock basis

Installment count 10 annual installments Cash settlement schedule after director service ends

Payout start window Within 60 days After end of calendar year in which director service ceases

Key Terms

Phantom Stock Units, Deferred Compensation Plan for Non-Employee Directors, dividend reinvestment provision, annual installments, +1 more

5 terms

Phantom Stock Units financial

"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

Deferred Compensation Plan for Non-Employee Directors financial

"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."

dividend reinvestment provision financial

"Includes 99.385 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."

A dividend reinvestment provision is a company policy that lets shareholders automatically use their cash dividends to buy more shares instead of receiving money. Think of it like a subscription that turns each payday into buying an extra slice of the same pie; it helps investors compound their holdings over time, often with lower transaction costs and sometimes at a small discount, which can boost long‑term returns and subtly change ownership percentages.

annual installments financial

"Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs."

Conversion or Exercise Price of Derivative Security is 1-for-1 financial

"The Conversion or Exercise Price of Derivative Security is 1-for-1."

FAQ

What insider transaction did ZIMMER BIOMET (ZBH) report for Arthur J. Higgins?

Arthur J. Higgins received a grant of 308.711 Phantom Stock Units. These units were awarded under Zimmer Biomet’s Deferred Compensation Plan for Non-Employee Directors and increase his total phantom stock holdings to 36,375.195 units after the transaction.

How many phantom stock units does Arthur J. Higgins hold after this ZBH Form 4?

After the reported grant, Arthur J. Higgins holds 36,375.195 Phantom Stock Units. This total includes the new 308.711-unit award and 99.385 units accrued on January 30, 2026 through the plan’s dividend reinvestment provision for non-employee directors.

What are the key terms of Arthur J. Higgins’ phantom stock units at ZIMMER BIOMET?

Each Phantom Stock Unit is based on a 1-for-1 conversion ratio with Zimmer Biomet common stock but is settled in cash. The units were accrued under the Deferred Compensation Plan for Non-Employee Directors rather than through open-market purchases or sales.

How and when will Arthur J. Higgins’ ZBH phantom stock units be paid out?

The phantom stock units will be settled in cash in ten annual installments. Payments begin within sixty days after the end of the calendar year in which Arthur J. Higgins’ service as a Zimmer Biomet director ceases, according to the plan terms.

Did the ZIMMER BIOMET Form 4 for Arthur J. Higgins involve open-market buying or selling of shares?

No, the Form 4 reflects a grant of Phantom Stock Units as compensation, not an open-market trade. The transaction is coded as a grant or award and units are accrued and later settled in cash under the non-employee directors’ deferred compensation plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HIGGINS ARTHUR J

(Last) (First) (Middle)

345 E. MAIN STREET

(Street)

WARSAW INDIANA 46580

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units(1)	$89.08(2)	03/31/2026		A		308.711		(3)	(3)	Common Stock	308.711	$0	36,375.195(4)	D

Explanation of Responses:

1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

2. The Conversion or Exercise Price of Derivative Security is 1-for-1.

3. Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

4. Includes 99.385 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

	/s/ Matthew R. St. Louis, Attorney-in-Fact for Arthur J. Higgins (power of attorney previously filed)	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)